China Resources Pharmaceutical (03320.HK) announced that its subsidiary Kunming Baker Norton has obtained production approval ...
1d
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
For an accessible version of this Press Release, please visit Q1 2026 revenues of ~$4.0 billion increased by 2% in U.S.
Access Conditionalities And Shortage Measures Compromise Proposal. Legal News and Analysis - EU, Europe - Regulatory & ...
Abstract: This study addresses the limitations of traditional active and semi-active suspension control systems in terms of adaptability and nonlinear handling, by exploring the potential of Deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results